Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.
Tiana S LuczakPaul J SchilloColleen M RenierStephen C WaringBret B FridayPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
In conclusion, we were able to show that implementation of preemptive pharmacogenetic testing into a community oncology clinic with results interpretation available prior to scheduled initiation of chemotherapy was feasible. As pharmacogenetic testing in oncology expands, pharmacists should be prepared to optimize supportive medication regimens as well as chemotherapy with pharmacogenetic results.